CAY10570 – 5 mg

Brand:
Cayman
CAS:
875014-22-5
Storage:
-20
UN-No:
De Minimis - 1231 / 3

The enzyme fatty acid amide hydrolase (FAAH) is capable of hydrolyzing and inactivating anandamide and other fatty acid amides that act as agonists for the central cannabinoid (CB1) receptor.{3310} CAY10570 is a reversible competitive inhibitor of FAAH activity exhibiting an IC50 value of 1.3 µM.{14794} CAY10570 has no affinity for the human CB1 receptor and acts as a competitive inhibitor of FAAH activity without being hydrolyzed by the enzyme.{14794}  

 

Available on backorder

SKU: 10010032 - 5 mg Category:

Description

A reversible inhibitor of FAAH activity exhibiting an IC50 value of 1.3 µM


Formal name: 3-decyl-5,5′-diphenyl-2-thioxo-4-imidazolidinone

Synonyms: 

Molecular weight: 408.6

CAS: 875014-22-5

Purity: >98%

Formulation: A solution in methyl acetate


Product Type|Biochemicals|Small Molecule Inhibitors|Fatty Acid Metabolism||Research Area|Neuroscience|Cannabinoid Research|Endocannabinoids